enCore Energy Corp. (NASDAQ:EU – Get Free Report) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 7,800,000 shares, an increase of 15.6% from the October 15th total of 6,750,000 shares. Approximately 4.3% of the shares of the company are sold short. Based on an average trading volume of 1,200,000 shares, the days-to-cover ratio is currently 6.5 days.
Analyst Upgrades and Downgrades
EU has been the topic of several recent analyst reports. Ventum Cap Mkts upgraded shares of enCore Energy to a “strong-buy” rating in a research report on Thursday, August 22nd. HC Wainwright reissued a “buy” rating and set a $7.00 price target on shares of enCore Energy in a report on Monday, October 7th.
Get Our Latest Research Report on enCore Energy
Hedge Funds Weigh In On enCore Energy
enCore Energy Price Performance
EU stock opened at $3.59 on Monday. enCore Energy has a 1-year low of $3.02 and a 1-year high of $5.05. The business has a 50 day simple moving average of $3.92 and a two-hundred day simple moving average of $3.99. The company has a market capitalization of $667.88 million, a price-to-earnings ratio of -12.82 and a beta of 0.05.
enCore Energy Company Profile
enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. It holds a 100% interest in Crownpoint and Hosta Butte uranium project area covers 3,020 acres located in the Grants Uranium Belt, New Mexico. The company also holds interest in the Marquez-Juan Tafoya property comprises 14,582 acres located in McKinley and Sandoval counties of New Mexico; and the Nose Rock project comprising 42 owned unpatented lode mining claims comprising approximately 800 acres located in McKinley County, New Mexico.
See Also
- Five stocks we like better than enCore Energy
- Trading Halts Explained
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 3 Monster Growth Stocks to Buy Now
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Why Are These Companies Considered Blue Chips?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for enCore Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enCore Energy and related companies with MarketBeat.com's FREE daily email newsletter.